RESUMEN
Yin Yang-1 (YY1) is a multifunctional transcription factor that can repress the expression of many growth factor, hormone, and cytokine genes implicated in atherogenesis. YY1 expression is activated in rat vascular smooth muscle cells shortly after injury. YY1 DNA binding activity paralleled elevated protein levels in the nucleus. Smooth muscle cell injury triggered the rapid extracellular release of immunoreactive fibroblast growth factor-2 (FGF-2). YY1 induction after injury was blocked by neutralizing antibodies directed against FGF-2. This growth factor increased YY1 mRNA and protein expression and stimulated YY1 binding and transcriptional activity. Overexpression of YY1 inhibited smooth muscle cell replication. Immunohistochemical analysis demonstrated YY1 staining in medial smooth muscle cells, coincident with FGF-2 expression. Proliferating cell nuclear antigen staining, in contrast, was confined mainly to the atherosclerotic intima. This is the first demonstration that YY1 is induced by either injury or FGF-2, is differentially expressed in normal and diseased human arteries, and that its overexpression inhibits vascular smooth muscle but not endothelial cell replication.
Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Endotelio Vascular/metabolismo , Factor 2 de Crecimiento de Fibroblastos/fisiología , Factores de Transcripción/biosíntesis , Animales , Arteriosclerosis/metabolismo , Secuencia de Bases , Células Cultivadas , Cartilla de ADN , Ensayo de Cambio de Movilidad Electroforética , Factores de Unión al ADN Específico de las Células Eritroides , Inmunohistoquímica , Ratas , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Transcripción YY1RESUMEN
Apoptosis of smooth muscle cells (SMC) in atherosclerotic vessels can destabilize the atheromatus plaque and result in rupture, thrombosis, and sudden death. In efforts to understand the molecular processes regulating apoptosis in this cell type, we have defined a novel mechanism involving the ubiquitously expressed transcription factor Sp1. Subtypes of SMC expressing abundant levels of Sp1 produce the death agonist, Fas ligand (FasL) and undergo greater spontaneous apoptosis. Sp1 activates the FasL promoter via a distinct nucleotide recognition element whose integrity is crucial for inducible expression. Inducible FasL promoter activation is also inhibited by a dominant-negative form of Sp1. Increased SMC apoptosis is preceded by Sp1 phosphorylation, increased FasL transcription, and the autocrine/paracrine engagement of FasL with its cell-surface receptor, Fas. Inducible FasL transcription and apoptosis are blocked by dominant-negative protein kinase C-zeta, whose wild-type counterpart phosphorylates Sp1. Thus, Sp1 phosphorylation is a proapoptotic transcriptional event in vascular SMC and, given the wide distribution of this housekeeping transcription factor, may be a common regulatory theme in apoptotic signal transduction.
Asunto(s)
Apoptosis , Glicoproteínas de Membrana/genética , Músculo Liso Vascular/citología , Factor de Transcripción Sp1/metabolismo , Receptor fas/metabolismo , Animales , Camptotecina/farmacología , Núcleo Celular/ultraestructura , Células Cultivadas , Fragmentación del ADN , Proteína Ligando Fas , Glicoproteínas de Membrana/biosíntesis , Glicoproteínas de Membrana/metabolismo , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/metabolismo , Fosforilación , Regiones Promotoras Genéticas , Proteína Quinasa C/fisiología , ARN Mensajero/biosíntesis , Ratas , Activación TranscripcionalRESUMEN
The capacity of DNA to bind RNA via Watson-Crick base-pairing is fundamental to antisense oligonucleotide strategies to inhibit gene expression, and is a property that has been exploited by bioengineers in the generation of catalytic molecules such as ribozymes, ribozyme subtypes, and more recently DNAzymes. This review describes the evolution of these gene-specific agents and summarizes recent efforts to inhibit smooth muscle cell growth with these molecules as candidate therapeutic tools in restenosis.
Asunto(s)
Reestenosis Coronaria/prevención & control , Regulación de la Expresión Génica , Ácidos Nucleicos/genética , Oligodesoxirribonucleótidos Antisentido/genética , Oligodesoxirribonucleótidos Antisentido/uso terapéutico , Animales , Emparejamiento Base , Reestenosis Coronaria/genética , ADN/genética , ADN Catalítico/genética , ADN Catalítico/uso terapéutico , ADN de Cadena Simple/genética , ADN de Cadena Simple/uso terapéutico , Marcación de Gen , Humanos , Músculo Liso Vascular/fisiología , ARN/genética , ARN Catalítico/genética , ARN Catalítico/uso terapéuticoRESUMEN
Early growth response factor-1 (Egr-1) binds to the promoters of many genes whose products influence cell movement and replication in the artery wall. Here we targeted Egr-1 using a new class of DNA-based enzyme that specifically cleaved Egr-1 mRNA, blocked induction of Egr-1 protein, and inhibited cell proliferation and wound repair in culture. The DNA enzyme also inhibited Egr-1 induction and neointima formation after balloon injury to the rat carotid artery wall. These findings demonstrate the utility of DNA enzymes as biological tools to delineate the specific functions of a given gene, and implicate catalytic nucleic acid molecules composed entirely of DNA as potential therapeutic agents.
Asunto(s)
División Celular/genética , ADN de Cadena Simple/metabolismo , Proteínas de Unión al ADN/genética , Proteínas Inmediatas-Precoces , Músculo Liso Vascular/citología , ARN Mensajero/metabolismo , Factores de Transcripción/genética , Animales , Secuencia de Bases , Sangre , Células Cultivadas , Proteínas de Unión al ADN/metabolismo , Proteína 1 de la Respuesta de Crecimiento Precoz , Regulación Enzimológica de la Expresión Génica , Humanos , Hidrólisis , Inmunohistoquímica , Músculo Liso Vascular/lesiones , ARN Mensajero/genética , Ratas , Factores de Transcripción/metabolismoRESUMEN
The early growth response 1 (Egr-1 or NGFI-A) gene product is a zinc finger protein transcription factor which has been implicated in the regulation of genes differentially expressed during the development of vascular disease. Egr-1 activity is regulated by alterations in the amount of protein, as well as protein-protein interactions with positive and negative transcriptional cofactors. NGFI-A-binding protein 2 (NAB2) is an example of a negative transcriptional cofactor capable of binding directly to Egr-1 and repressing Egr-1-mediated transcription. In this study, we show that NAB2 is rapidly and transiently expressed in vascular smooth muscle cells (VSMC) in response to the model agonist phorbol 12-myristate 13-acetate (PMA). This induction occurs at the protein as well as mRNA level, and the time course of induction trails closely behind that of Egr-1. NAB2 expression in VSMC is capable of inhibiting Egr-1 dependent gene expression in response to either PMA or fibroblastic growth factor-2 (FGF-2). In an in vivo model of mechanical arterial injury NAB2 levels also increase transiently in VSMC at a time when Egr-1 is elevated. It is possible that NAB2 is part of a negative-feedback mechanism which serves to down-regulate Egr-1-mediated gene transcription in injured VSMC.
Asunto(s)
Proteínas Inmediatas-Precoces , Músculo Liso Vascular/lesiones , Músculo Liso Vascular/metabolismo , Proteínas de Neoplasias , Proteínas Represoras/biosíntesis , Animales , Northern Blotting , Western Blotting , Bovinos , División Celular/genética , Movimiento Celular/genética , Núcleo Celular/metabolismo , Células Cultivadas , Proteínas de Unión al ADN/metabolismo , Proteína 1 de la Respuesta de Crecimiento Precoz , Factor 2 de Crecimiento de Fibroblastos/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Hibridación in Situ , Masculino , Músculo Liso Vascular/citología , Músculo Liso Vascular/efectos de los fármacos , Factor de Crecimiento Derivado de Plaquetas/metabolismo , ARN Mensajero/metabolismo , Ratas , Acetato de Tetradecanoilforbol/farmacología , Factores de Tiempo , Factores de Transcripción/metabolismoRESUMEN
Smooth muscle cell (SMC) proliferation is a key event in renarrowing of blood vessels after balloon angioplasty. Mechanical injury imparted to the arterial wall in experimental models induces the expression of the immediate-early gene, egr-1. Egr-1 binds to and activates expression from the proximal promoters of multiple genes whose products can, in turn, influence the vascular response to injury. Here, we used antisense strategies in vitro to inhibit rat vascular SMC proliferation by directly targeting Egr-1. A series of phosphorothioate antisense oligonucleotides of 15 base length and complementary to various theoretically accessible regions within Egr-1 mRNA were synthesized and assessed for their ability to selectively inhibit SMC proliferation in an Egr-1-dependent manner. Western blot analysis revealed that two oligonucleotides, AS2 and E11, inhibited Egr-1 synthesis in cells exposed to serum without affecting levels of the zinc finger protein Sp1. AS2 and E11 inhibited serum-inducible [(3)H]thymidine incorporation into DNA, as well as serum stimulation of total cell numbers. Size-matched phosphorothioate oligonucleotides with random, scrambled, sense or mismatch sequences failed to inhibit. Antisense Egr-1 inhibition was nontoxic and reversible. These oligonucleotides also inhibited SMC regrowth after mechanical injury in vitro. Egr-1 thus plays a key regulatory role in SMC proliferation and repair following injury.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Proteínas Inmediatas-Precoces , Músculo Liso Vascular/citología , Factores de Transcripción/fisiología , Animales , Sitios de Unión , Proteínas Sanguíneas/farmacología , Western Blotting , División Celular/efectos de los fármacos , Células Cultivadas , Proteínas de Unión al ADN/antagonistas & inhibidores , Proteínas de Unión al ADN/genética , Proteína 1 de la Respuesta de Crecimiento Precoz , Fluoresceína-5-Isotiocianato , Expresión Génica/efectos de los fármacos , Microscopía Fluorescente , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/lesiones , Músculo Liso Vascular/metabolismo , Conformación de Ácido Nucleico , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , Oligonucleótidos Antisentido/metabolismo , Oligonucleótidos Antisentido/farmacocinética , Radioisótopos de Fósforo , Factor de Crecimiento Derivado de Plaquetas/biosíntesis , ARN Mensajero/efectos de los fármacos , Ratas , Tionucleótidos/farmacocinética , Tionucleótidos/farmacología , Factores de Tiempo , Factores de Transcripción/antagonistas & inhibidores , Factores de Transcripción/genéticaRESUMEN
Platelet-derived growth factor (PDGF) is a mitogen and chemoattractant for a wide variety of cell types. The genes encoding PDGF A chain (PDGF-A) and PDGF B chain (PDGF-B) reside on separate chromosomes and are independently regulated at the level of transcription. Regulatory events underlying inducible PDGF-A expression have been the focus of much investigation. However, mechanisms that inhibit transcription of this gene are not well understood. In this study, we report the capacity of a newly cloned DNA binding factor, GC factor 2 (GCF2), to repress expression driven by the human PDGF-A promoter. 5' Deletion and transient cotransfection analysis in vascular endothelial cells revealed that GCF2 repression is mediated by a nucleotide region located in the proximal region of the PDGF-A promoter. Electrophoretic mobility shift assays demonstrate that GCF2 binds to this region in a specific and dose-dependent manner. Interestingly, the site bound by GCF2 overlaps those for specificity protein-1 (Sp1) and early growth response factor-1 (Egr-1), zinc finger transcription factors that direct basal and inducible expression of the PDGF-A gene. Gel shift experiments revealed that GCF2 competes with these factors for interaction with the PDGF-A promoter. Overexpression of GCF2 suppressed endogenous PDGF-A expression in vascular endothelial cells and smooth muscle cells. GCF2 was induced on mechanical injury of cells in culture as well as after balloon injury of the rat carotid artery wall. Time course studies revealed the sustained induction of GCF2 after injury while PDGF-A levels sharply returned to baseline. Smooth muscle cell proliferation was inhibited by GCF2, an effect reversed by the addition of exogenous PDGF-AA. These findings demonstrate negative regulation of PDGF-A expression by GCF2. This is the first report of the induction of an endogenous transcriptional repressor in the rat vessel wall.
Asunto(s)
Proteínas de Unión al ADN/genética , Endotelio Vascular/lesiones , Factor de Crecimiento Derivado de Plaquetas/genética , Proteínas Represoras/genética , Factores de Transcripción/genética , Transcripción Genética , Animales , Aorta/lesiones , Aorta/patología , Bovinos , Células Cultivadas , Endotelio Vascular/patología , Factores de Unión a la G-Box , Humanos , Músculo Liso Vascular/lesiones , Músculo Liso Vascular/patología , Regiones Promotoras Genéticas , Unión Proteica , Ratas , Ratas Sprague-Dawley , Estrés Mecánico , Dedos de ZincRESUMEN
Cell migration and proliferation that follows injury to the artery wall is preceded by signaling and transcriptional events that converge at the promoters of multiple genes whose products can influence formation of the neointima. Transcription factors, such as early growth response factor-1 (Egr-1), with nucleotide recognition elements in the promoters of many pathophysiologically relevant genes, are expressed at the endothelial wound edge within minutes of injury. The mechanisms underlying the inducible expression of Egr-1 in this setting are not clear. Understanding this process would provide important mechanistic insights into the earliest events in the response to injury. In this report, we demonstrate that fibroblast growth factor-2 (FGF-2) is released by injury and that antibodies to FGF-2 almost completely abrogate the activation and nuclear accumulation of Egr-1. FGF-2-inducible egr-1-promoter-dependent expression is blocked by PD98059, a specific inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK)-1/2 (MEK-1/2), as well as by dominant negative mutants of ERK-1/2. Inducible ERK phosphorylation after injury is dependent on release and stimulation by endogenous FGF-2. Antisense oligonucleotides directed at egr-1 mRNA suggest that Egr-1 plays a necessary role in endothelial repair after denudation of the monolayer. These findings demonstrate that inducible Egr-1 expression after injury is contingent on the release and paracrine action of FGF-2.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Quinasas de Proteína Quinasa Activadas por Mitógenos , Proteínas Quinasas Activadas por Mitógenos , Comunicación Paracrina/fisiología , Factores de Transcripción/metabolismo , Animales , Aorta/citología , Aorta/metabolismo , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Proteínas Quinasas Dependientes de Calcio-Calmodulina/fisiología , Bovinos , Células Cultivadas , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/fisiología , Endotelio Vascular/citología , Endotelio Vascular/lesiones , Endotelio Vascular/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos , MAP Quinasa Quinasa 1 , Proteínas Nucleares/metabolismo , Regiones Promotoras Genéticas/fisiología , Proteínas Serina-Treonina Quinasas/fisiología , Proteínas Tirosina Quinasas/fisiología , Factor de Respuesta Sérica , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Cicatrización de Heridas/fisiología , Heridas y Lesiones/enzimologíaRESUMEN
Point mutations in the K-ras gene are frequently observed in a variety of human malignancies, including colorectal and pancreatic cancers. In this paper, we describe a sensitive procedure for the detection of point mutations of codon 12 of the K-ras gene. The assay employs a single-tube enriched PCR procedure, coupled to colorimetric detection. In the enriched PCR procedure, the first round of amplification introduces a restriction enzyme site in the wild type, but not in mutant K-ras PCR product. The wild type products are then digested and the second round of PCR enriches for the mutant sequences by amplifying the resistant products. The second round of amplification allows the incorporation of biotin and a substrate binding tag at opposite ends of the mutant product, thus allowing detection of the product by a simple colorimetric assay. The assay has been validated using DNA from a variety of cell lines known to contain either mutant or wild type K-ras. Under these conditions, the assay has proved both reproducible and sensitive, with the ability to detect one mutant molecule in a background of 1000 wild type molecules. The assay allowed discrimination of mutant from wild type K-ras in samples from colonic adenocarcinomas and normal colonic mucosa. The use of a colorimetric detection system reduces observer bias and facilitates analysis of large numbers of samples. As such, the assay may have specific application in the sensitive detection of K-ras mutations in a variety of clinical samples.
Asunto(s)
Adenocarcinoma/genética , Neoplasias del Colon/genética , Colorimetría , ADN de Neoplasias/genética , Genes ras , Mutación Puntual , Reacción en Cadena de la Polimerasa/métodos , Codón , Cartilla de ADN , Genes ras/genética , Humanos , Mutación Puntual/genética , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Células Tumorales CultivadasRESUMEN
A number of minimised hammerhead ribozymes (minizymes) which lack stem II have been kinetically characterised. These minizymes display optimal cleavage activity at temperatures around 37 degrees C. The cleavage reactions of the minizymes are first order in hydroxide ion concentration up to around pH 9.3 above which the cleavage rate constants decline rapidly. The reactions show a biphasic dependence on magnesium-ion concentration; one of the interactions has an apparent dissociation constant of around 20 mM while the other appears to be very weak, showing no sign of saturation at 200 mM MgCl2. The minizymes are significantly less active than comparable, full-size ribozymes when cleaving short substrates. However, at a particular site in a transcribed TAT gene from HIV-1, minizymes are more effective than ribozymes.
Asunto(s)
ARN Catalítico/metabolismo , Proteínas Represoras , Animales , Secuencia de Bases , Proteínas de Unión al ADN/genética , Drosophila melanogaster/genética , Genes tat , Hormona del Crecimiento/genética , VIH-1/genética , Concentración de Iones de Hidrógeno , Cinética , Factores de Transcripción de Tipo Kruppel , Magnesio/farmacología , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , ARN Catalítico/química , ARN Mensajero/química , ARN Mensajero/metabolismo , Ratas , Especificidad por Sustrato , Temperatura , Factores de Transcripción/genéticaRESUMEN
Hammerhead ribozymes cleave RNA substrates containing the UX sequence, where X = U, C or A, embedded within sequences which are complementary to the hybridising 'arms' of the ribozyme. In this study we have replaced the RNA in the hybridising arms of the ribozyme with DNA, and the resulting ribozyme is many times more active than its precursor. In turnover-kinetics experiments with a 13-mer RNA substrate, the kcat/Km ratios are 10 and 150 microM-1min-1 for the RNA- and DNA-armed ribozymes, respectively. The effect is due mainly to differences in kcat. In independent experiments where the cleavage step is rate-limiting, the DNA-armed ribozyme cleaves the substrate with a rate constant more than 3 times greater than the all-RNA ribozyme. DNA substrates containing a ribocytidine at the cleavage site have been shown to be cleaved less efficiently than their all-RNA analogues; again however, the DNA-armed ribozyme is more effective than the all-RNA ribozyme against such DNA substrates. These results demonstrate that there are no 2'-hydroxyl groups in the arms of the ribozyme that are required for cleavage; and that the structure of the complex formed by the DNA-armed ribozyme with its substrate is more favourable for cleavage than that formed by the all-RNA ribozyme and its substrate.
Asunto(s)
ADN/metabolismo , ARN Catalítico/metabolismo , Animales , Secuencia de Bases , Sangre , Bovinos , Estabilidad de Enzimas , Cinética , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , ARN/metabolismo , ARN Catalítico/química , Especificidad por SustratoRESUMEN
The rfbB gene (dThymidine-diphospho-D-glucose-4,6-dehydratase) from Salmonella serovar typhimurium LT2 was cloned and over-expressed using the T7 RNA polymerase/promoter system. The expressed protein, which represents almost 10% of the total cellular protein was purified 14-fold. dTDP-D-glucose 4,6-dehydratase is a homodimer of 43 kDa subunits, is highly specific for dTDP-D-glucose and shows a Km of 427 microM and Vmax of 0.93 mu moles min-1 micrograms-1 of protein for dTDP-D-glucose. The N-terminal analysis confirmed the start position of the gene in the DNA sequence. Complete deactivation of the enzyme by the addition of p-chloromercurisulfonic acid and total reactivation by the addition of mercaptoethanol, co-factor NAD+ and cystein showed that a -SH group of the cysteine is involved in the catalytic site.